162 related articles for article (PubMed ID: 37024553)
1. Pharmacological inhibition of the inflammatory receptor CCR2 relieves the early deleterious consequences of status epilepticus.
Alemán-Ruiz C; Wang W; Dingledine R; Varvel NH
Sci Rep; 2023 Apr; 13(1):5651. PubMed ID: 37024553
[TBL] [Abstract][Full Text] [Related]
2. Infiltrating monocytes promote brain inflammation and exacerbate neuronal damage after status epilepticus.
Varvel NH; Neher JJ; Bosch A; Wang W; Ransohoff RM; Miller RJ; Dingledine R
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5665-74. PubMed ID: 27601660
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Myeloid Cell EP2 Activation Contributes to the Deleterious Consequences of Status Epilepticus.
Varvel NH; Espinosa-Garcia C; Hunter-Chang S; Chen D; Biegel A; Hsieh A; Blackmer-Raynolds L; Ganesh T; Dingledine R
J Neurosci; 2021 Feb; 41(5):1105-1117. PubMed ID: 33293358
[TBL] [Abstract][Full Text] [Related]
4. Chemokine CCL2-CCR2 Signaling Induces Neuronal Cell Death via STAT3 Activation and IL-1β Production after Status Epilepticus.
Tian DS; Peng J; Murugan M; Feng LJ; Liu JL; Eyo UB; Zhou LJ; Mogilevsky R; Wang W; Wu LJ
J Neurosci; 2017 Aug; 37(33):7878-7892. PubMed ID: 28716963
[TBL] [Abstract][Full Text] [Related]
5. Microglial proliferation and monocyte infiltration contribute to microgliosis following status epilepticus.
Feng L; Murugan M; Bosco DB; Liu Y; Peng J; Worrell GA; Wang HL; Ta LE; Richardson JR; Shen Y; Wu LJ
Glia; 2019 Aug; 67(8):1434-1448. PubMed ID: 31179602
[TBL] [Abstract][Full Text] [Related]
6. A Novel Second-Generation EP2 Receptor Antagonist Reduces Neuroinflammation and Gliosis After Status Epilepticus in Rats.
Rojas A; Amaradhi R; Banik A; Jiang C; Abreu-Melon J; Wang S; Dingledine R; Ganesh T
Neurotherapeutics; 2021 Apr; 18(2):1207-1225. PubMed ID: 33410110
[TBL] [Abstract][Full Text] [Related]
7. Monocytes promote acute neuroinflammation and become pathological microglia in neonatal hypoxic-ischemic brain injury.
Chen HR; Chen CW; Kuo YM; Chen B; Kuan IS; Huang H; Lee J; Anthony N; Kuan CY; Sun YY
Theranostics; 2022; 12(2):512-529. PubMed ID: 34976198
[No Abstract] [Full Text] [Related]
8. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus.
Foresti ML; Arisi GM; Katki K; Montañez A; Sanchez RM; Shapiro LA
J Neuroinflammation; 2009 Dec; 6():40. PubMed ID: 20034406
[TBL] [Abstract][Full Text] [Related]
9. Spatio-temporal profile, phenotypic diversity, and fate of recruited monocytes into the post-ischemic brain.
Garcia-Bonilla L; Faraco G; Moore J; Murphy M; Racchumi G; Srinivasan J; Brea D; Iadecola C; Anrather J
J Neuroinflammation; 2016 Nov; 13(1):285. PubMed ID: 27814740
[TBL] [Abstract][Full Text] [Related]
10. CCR2 antagonism alters brain macrophage polarization and ameliorates cognitive dysfunction induced by traumatic brain injury.
Morganti JM; Jopson TD; Liu S; Riparip LK; Guandique CK; Gupta N; Ferguson AR; Rosi S
J Neurosci; 2015 Jan; 35(2):748-60. PubMed ID: 25589768
[TBL] [Abstract][Full Text] [Related]
11. Chemokine signaling mediated monocyte infiltration affects anxiety-like behavior following blast injury.
Murugan M; Ravula A; Gandhi A; Vegunta G; Mukkamalla S; Mujib W; Chandra N
Brain Behav Immun; 2020 Aug; 88():340-352. PubMed ID: 32240765
[TBL] [Abstract][Full Text] [Related]
12. C-C chemokine receptor type 2 (CCR2) signaling protects neonatal male mice with hypoxic-ischemic hippocampal damage from developing spatial learning deficits.
Pimentel-Coelho PM; Michaud JP; Rivest S
Behav Brain Res; 2015 Jun; 286():146-51. PubMed ID: 25746456
[TBL] [Abstract][Full Text] [Related]
13. Cranial irradiation alters the brain's microenvironment and permits CCR2+ macrophage infiltration.
Morganti JM; Jopson TD; Liu S; Gupta N; Rosi S
PLoS One; 2014; 9(4):e93650. PubMed ID: 24695541
[TBL] [Abstract][Full Text] [Related]
14. Chronic alcohol-induced neuroinflammation involves CCR2/5-dependent peripheral macrophage infiltration and microglia alterations.
Lowe PP; Morel C; Ambade A; Iracheta-Vellve A; Kwiatkowski E; Satishchandran A; Furi I; Cho Y; Gyongyosi B; Catalano D; Lefebvre E; Fischer L; Seyedkazemi S; Schafer DP; Szabo G
J Neuroinflammation; 2020 Oct; 17(1):296. PubMed ID: 33036616
[TBL] [Abstract][Full Text] [Related]
15. Treatment with CCR2 antagonist is neuroprotective but does not alter epileptogenesis in the pilocarpine rat model of epilepsy.
Foresti ML; Arisi GM; Campbell JJ; Mello LE
Epilepsy Behav; 2020 Jan; 102():106695. PubMed ID: 31785482
[TBL] [Abstract][Full Text] [Related]
16. Chemokine receptors CCR2 and CX3CR1 regulate viral encephalitis-induced hippocampal damage but not seizures.
Käufer C; Chhatbar C; Bröer S; Waltl I; Ghita L; Gerhauser I; Kalinke U; Löscher W
Proc Natl Acad Sci U S A; 2018 Sep; 115(38):E8929-E8938. PubMed ID: 30181265
[TBL] [Abstract][Full Text] [Related]
17. CCR2+ Ly6C(hi) inflammatory monocyte recruitment exacerbates acute disability following intracerebral hemorrhage.
Hammond MD; Taylor RA; Mullen MT; Ai Y; Aguila HL; Mack M; Kasner SE; McCullough LD; Sansing LH
J Neurosci; 2014 Mar; 34(11):3901-9. PubMed ID: 24623768
[TBL] [Abstract][Full Text] [Related]
18. Seizure suppression and neuroprotection by targeting the purinergic P2X7 receptor during status epilepticus in mice.
Engel T; Gomez-Villafuertes R; Tanaka K; Mesuret G; Sanz-Rodriguez A; Garcia-Huerta P; Miras-Portugal MT; Henshall DC; Diaz-Hernandez M
FASEB J; 2012 Apr; 26(4):1616-28. PubMed ID: 22198387
[TBL] [Abstract][Full Text] [Related]
19. Ccr2 deletion dissociates cavity size and tau pathology after mild traumatic brain injury.
Gyoneva S; Kim D; Katsumoto A; Kokiko-Cochran ON; Lamb BT; Ransohoff RM
J Neuroinflammation; 2015 Dec; 12():228. PubMed ID: 26634348
[TBL] [Abstract][Full Text] [Related]
20.
Sharma R; Chu E; Dill LK; Shad A; Zamani A; O'Brien TJ; Casillas-Espinosa PM; Shultz SR; Semple BD
J Neurotrauma; 2023 Feb; 40(3-4):365-382. PubMed ID: 36070444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
